Linear discriminant analysis for skin sensitisation potential of diverse organic chemicals

Molecular Simulation

Volumn 39, Issue 6, 2013, Pages 432-441

  Nandy, Ashis ^a   Kar, Supratik ^a   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

linear discriminant analysis; murine local lymph node assay; organisation for economic co operation and development; quantitative structure activity relationship; registration, evaluation and authorisation of chemicals

Indexed keywords

CONTRIBUTION PLOTS; LINEAR DISCRIMINANT ANALYSIS; LYMPH NODE; MOLECULAR FLEXIBILITY; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PREDICTIVE MODELS; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; STIMULATION INDICES;

BODY FLUIDS; SOCIETIES AND INSTITUTIONS;

ORGANIC CHEMICALS;

EID: 84876285710     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2012.738421     Document Type: Article

References (36)

1. J.P. Thyssen, E. Gimenez-Arnau, J.P. Lepoittevin, T. Menne, A. Boman, and A. Schnuch, The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals Part I, Contact Dermatitis 66 (2012), pp. 11-24.
2. Y. Li, Y.J. Tseng, D. Pan, J. Liu, P.S. Kern, G.F. Gerberick, and A.J. Hopfinger, 4D-fingerprint categorical QSAR models for skin sensitization based on classification local lymph node assay measures, Chem. Res. Toxicol. 20 (2007), pp. 114-128.
3. F. Hasdenteufel, S. Luyasu, N. Hougardy, M. Fisher, M. Boisbrun, P.M. Mertes, and G. Kanny, Structure-activity relationships and drug allergy, Curr. Clin. Pharmacol. 7 (2012), pp. 15-27.
4. W. Lund, Good manufacturing practices. The Pharmaceutical Codex: Principle and Practice of Pharmaceutics, 12th ed., The Pharmaceutical Press, London, 1994, pp. 362-397.
5. R. Benigni and A. Giuliani, Putting the predictive toxicology challenge into perspective: Reflections on the results, Bioinformatics 19 (2003), pp. 1194-1200.
6. EC2003. 2003/15/EC. Commission Directive of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of laws of the Meber States relating to cosmetic products, Off. J. Eur. Union L66, pp. 26-35. Available at http://www.europa.eu.int/comm/environment/chemicals/index.html
7. S. Kar and K. Roy, Predictive toxicology using QSAR: A perspective, J. Indian Chem. Soc. 87 (2010), pp. 1455-1515.
8. Organization for Economic Cooperation and Development (OECD), 2007. Guidance document on the validation of (quantitative) structure-activity relationships [(Q) SAR] models, ENV/JM/MONO 2 (2007), 1-154.
9. S. Kar and K. Roy, Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs, Indian J. Biochem. Biophys. 48 (2011), pp. 111-122.
10. G. Maxwell and C. MacKay, Application of a systems biology approach for skin allergy risk assessment, Jpn. Soc. Altern. Anim. Exp. 14 (2008), pp. 381-388.
11. A. Fedorowicz, L. Zheng, H. Singh, and E. Demchuk, QSAR study of skin sensitization using local lymph node assay data, Int. J. Mol. Sci. 5 (2004), pp. 56-66.
12. Y. Li, D. Pan, J. Liu, P.S. Kern, G.F. Gerberick, A.J. Hopfinger, and Y.J. Tseng, Categorical QSAR models for skin sensitization based upon local lymph node assay classification measures part 2: 4Dfingerprint. Three-state and two-2-state logistic regression model, Toxicol. Sci. 99 (2007), pp. 532-544.
13. J. Lu, M. Zheng, Y. Wang, Q. Shen, X. Luo, H. Jiang, and K. Chen, Fragment-based prediction of skin sensitization using recursive partitioning, J. Comput. Aided. Mol. Des. 25 (2011), pp. 885-893.
14. R.J. Vandebriel and H. Loverenl, Non-animal sensitization testing: State-of-the-art, Crit. Rev. Toxicol. 40 (2010), pp. 389-404.
15. M. Murcia-Soler, F. Perez-Gimenez, F.J. Garcya-March, M.T. Salabert-Salvador, W. Dýaz-Villanueva, and P. Medina-Casamayor, Discrimination and selection of new potential antibacterial compounds using simple topological descriptors, J. Mol. Graphics Modell. 21 (2003), pp. 375-390.
16. E. Kemsley, Discriminant analyses of high-dimensional data: A comparison of principal component analysis and partial least squares data reduction methods, Chemom. Intell. Lab. Syst. 33 (1996), pp. 47-61.
17. M. Barker and W. Rayens, Partial least squares for discrimination, J. Chemom. 17 (2002), pp. 166-173.
18. D.W. Roberts, A.O. Aptula, and G. Patlewicz, Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization, Chem. Res. Toxicol. 19 (2006), pp. 1228-1233.
19. MarvinSketch 5.10.0. ChemAxon Ltd., 1998-2012; software available at http://www.chemaxon.com
20. C.W. Yap, PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem. 32 (2011), pp. 1466-1474.
21. DRAGON ver. 6. TALETE srl, Italy; software available at http://www.talete.mi.it/products/dragon-molecular-descriptors.htm
22. K. Roy, On some aspects of validation of predictive QSAR models, Expert Opin. Drug Discov. 2 (2007), pp. 1567-1577.
23. J.T. Leonard and K. Roy, On selection of training and test sets for the development of predictive QSAR models, QSAR Comb. Sci. 25 (2006), pp. 235-251.
24. K. Roy and I. Mitra, On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design, Comb. Chem. High Throughput Screen. 14 (2011), pp. 450-474.
25. M. Galvez-Llompart, M.C. Recio, and R. Garcýa-Domenech, Topological virtual screening: A way to find new compounds active in ulcerative colitis by inhibiting NF-kB, Mol. Divers. 15 (2011), pp. 917-926.
26. B.W. Matthews, Comparison of the predicted and observed secondary structure of T4 phage lysozime, Biochim. Biophys. Acta. 405 (1975), pp. 442-451.
27. T. Fawcett, An introduction to ROC analysis, Pattern. Recogn. Lett. 27 (2006), pp. 861-874.
28. A. Perez-Garrido, A.M. Helguera, F. Borges, M.N.D.S. Cordeiro, V. Rivero, and A.G. Escudero, Two new parameters based on distances in a receiver operating characteristic chart for the selection of classification models, J. Chem. Inf. Model. 51 (2011), pp. 2746-2759.
29. M. Murcia-Soler, F. Perez-Gimenez, F. Garccýa-March, M. Salabert-Salvador, W. Dcýaz-Villanuev, and P. Medina-Casamayor, Discrimination and selection of new potential antibacterial compounds using simple topological descriptors, J. Mol. Graph. Model. 21 (2003), pp. 375-390.
30. M.A. Bergstrom, K. Luthman, J.L.G. Nilsson, and A.T. Karlberg, Conjugated dienes as prohaptens in contact allergy: In vivo and in vitro studies of structure-activity relationships, sensitizing capacity, and metabolic activation, Chem. Res. Toxicol. 19 (2006), pp. 760-769.
31. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem. 45 (2002), pp. 2615-2623.
32. P.V. Khadikar, V.K. Agrawalb, and S. Karmarkara, Prediction of lipophilicity of polyacenes using quantitative structure-activity relationships, Bioorg. Med. Chem. 10 (2002), pp. 3499-3507.
33. P. Griem, C. Goebel, and H. Scheffler, Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data, Regul. Toxicol. Pharm. 38 (2003), pp. 269-290.
34. J. Jaworska, N. Nikolova-Jeliazkova, and T. Aldenberg, QSAR applicability domain estimation byprojection of the training set descriptor space: A review, Altern. Lab. Anim. 33 (2005), pp. 445-459.
35. C. Knox, V. Law, T. Jewison, P. Liu, S. Ly, A. Frolkis, A. Pon, K. Banco, C. Mak, V. Neveu, Y. Djoumbou, R. Eisner, A.C. Guo, and D.S. Wishart, DrugBank, Nucleic Acids Res. 39 (2011), pp. D1035-D1041.
36. T. Matsushita and R. Kamide, Five cases of photocontact dermatitis due to topical ketoprofen: Photopatch testing and cross-reaction study, Photodermatol. Photoimmunol. Photomed. 17 (2001), pp. 26-31.